March 17, 2020 / 1:32 PM / in 14 days

BRIEF-MannKind Refocuses Pipeline Resources In Response To COVID-19 Pandemic

March 17 (Reuters) - MannKind Corp:

* MANNKIND REFOCUSES PIPELINE RESOURCES IN RESPONSE TO COVID-19 PANDEMIC

* MANNKIND - ADJUSTING RESEARCH & DEVELOPMENT RESOURCES THAT WERE RESERVED FOR PIPELINE OF INVESTIGATIONAL PRODUCTS FOR TREATING SERIOUS LUNG DISEASES

* MANNKIND - INITIATED COLLABORATION WITH IMMIX BIOPHARMA TO PREPARE DRY POWDER FORMULATION OF COMPOUND TO TREAT ACUTE RESPIRATORY DISTRESS SYNDROME

* MANNKIND - OTHER COLLABORATIONS ARE BEING ACTIVELY EXPLORED AT THIS TIME Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below